Clinical Trials on Head Cancer in Belgium

Total 1799 results

University Hospital, Ghent
Fund for Scientific Research, Flanders, Belgium

Completed

A Study of the Effect on Oro-dental Complications of Intensity Modulated Radiotherapy (IMRT) Versus Conventional Radiotherapy in Patients With Cancer of the Head or Neck

Cancer: Head or Neck

Belgium
AZ Sint-Jan AV

Recruiting

Value of Geriatric Screening to Predict Postoperative Morbidity for Head and Neck Cancer (GEROP)

Head and Neck

Belgium
Jules Bordet Institute

Unknown

NIR Fluorescence Imaging During Neck Dissection in Head and Neck Cancer Patients After iv Injection of ICG

Head and Neck Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
University Hospital, Ghent

Completed

Dose De-escalation to the Elective Nodal Sites in Head and Neck Cancer

Head and Neck Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...
Merck Sharp & Dohme LLC; Merck Serono International SA

Completed

Neoadjuvant Cetuximab in HNSCC Combined With Curative Surgery (CHIRON)

Head and Neck Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Unknown

Molecular Imaging-based Dose Escalation in HPV Negative Patients With Locally Advanced SCC of the Oropharynx

Head and Neck Cancer

Belgium
University Hospital, Ghent
Universitaire Ziekenhuizen KU Leuven; University Ghent; Centre Oscar Lambret; Maastro...

Completed

Predictive Modelling for Patient Stratification According to Treatment-related Toxicity and Survival After Chemoradiation for Head and Neck Cancer (PRETOXIS)

Head and Neck Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
Kom Op Tegen Kanker

Recruiting

Effect of Exercise in Head and Neck Cancer Patients (EffEx-HN)

Head and Neck Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
Flemish League Against Cancer

Recruiting

Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology

Head and Neck Cancer

Belgium
Harrison Clinical Research
Merck KGaA, Darmstadt, Germany; AstraZeneca

Completed

Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/Gefitinib

Head and Neck Cancer | Colorectal Cancer | Non Small Cell Lung Cancer (NSCLC)

Spain, Belgium
KU Leuven

Completed

Survival Analysis of Oral Cancer Patients

Head and Neck Cancer

Belgium
University Hospital, Ghent

Completed

A Feasibility Study on Adaptive 18F-FDG-guided Radiotherapy for Recurrent and Second Primary Head and Neck Cancer in the Previously Irradiated Territory.

Re-irradiation in Recurrent and Second Primary Head and Neck Cancer

Belgium
Hasselt University
Jessa Hospital

Completed

Laser Therapy for the Prevention of Radiodermatitis in Head and Neck Patients (DERMISHEAD)

Head Cancer | Neck Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Recruiting

Patient-derived Xenograft Models of Tumor From Patients With Head and Neck Cancer (UCL-Xenog)

Squamous Cell Carcinoma of the Head and Neck

Belgium
Jules Bordet Institute

Active, not recruiting

Prospective Pilot Study Evaluating Dental Side Effects of Radiotherapy on Subjects Treated for Head and Neck Cancer (StomRay)

Head and Neck Squamous Cell Carcinoma

Belgium
Gustave Roussy, Cancer Campus, Grand Paris

Recruiting

Study Evaluating Near-infrared Imaging Coupled With Indocyanine Green for Intraoperative Control of Resection Margins in ENT Surgery (MAGNOLIA)

Head and Neck Cancer

Belgium, France
AZ Sint-Jan AV

Active, not recruiting

Use of Multiparametric MRI in the Management of Head and Neck Cancer: a Prospective Analysis

Head and Neck Cancer | Multiparametric MRI | Cervical Lymph Node | Treatment Response | Bone Invasion | Tumour Relapse

Belgium
European Organisation for Research and Treatment...

Terminated

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

Head and Neck Cancer

Belgium
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx

Head and Neck Cancer

Belgium
Novartis Pharmaceuticals

Completed

A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck Cancer

Esophageal Cancer | Prostate Cancer | Head & Neck Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
Flemish League Against Cancer

Terminated

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer

Belgium
General Hospital Groeninge
University Hospital, Ghent

Completed

Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy (NUTRIOM)

Head and Neck Cancer | Cancer Cachexia

Belgium
University Hospital, Ghent
Stichting tegen Kanker

Recruiting

Patient Education Videos to Improve Patients' Experience During Radiotherapy Treatment: a National Project

Cancer Head Neck | Cancer, Breast | Cancer, Lung | Cancer Prostate | Cancer, Gastrointestinal

Belgium
University Hospital, Ghent
General Hospital Groeninge; Anglia Ruskin University; KU Leuven Campus Kulak...

Withdrawn

Study of Efficacy and Safety of Gabapentin to Reduce the Need for Strong Opioid Use in Head and Neck Cancer Patients. (stREnGTH)

Head Neck Cancer | Pain, Neuropathic | Radiation Neuropathy

Belgium
Jessa Hospital

Withdrawn

A Novel Skin Barrier Protectant for Acute Radiodermatitis (CASP-ORL)

Skin Diseases | Head and Neck Cancer | Radiation Toxicity | Radiodermatitis | Radiation Dermatitis

Belgium
University Hospital, Ghent

Completed

Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) in Patients With Head and Neck Tumor

Head and Neck Tumor

Belgium
Cliniques universitaires Saint-Luc- Université...

Terminated

A Study of CP-751,871 in Patients With Recurrent Squamous Head and Neck Carcinoma

Head and Neck Cancer

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Effects of High-intensity Training Compared to Resistance Training in Cancer Patients Undergoing Radiotherapy

Head and Neck Cancer | Prostate Cancer | Rectum Cancer

Belgium
Genmab

Completed

Zalutumumab Pharmacokinetics (PK) in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Head and Neck Cancer

United Kingdom, Belgium, Slovakia, Hungary
University Hospital, Ghent

Completed

A Feasibility Study On Continuous Adaptive [18f]Fdg-Pet-Guided Radiotherapy For Head and Neck Cancer

Squamous Cell Carcinoma

Belgium
Cancer Research Antwerp

Recruiting

Masks Against Surface-Scanning for Radiation Therapy Immobilisation in Head and Neck Cancer (MASSC) (MASSC)

Head and Neck Neoplasm

Belgium
Jules Bordet Institute

Active, not recruiting

Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features

Head and Neck Cancer | Dysphagia

Belgium
Genmab

Terminated

Zalutumumab in Combination With Chemotherapy and Radiotherapy in Head and Neck Cancer

Head and Neck Cancer | Squamous Cell Cancer

Belgium, Sweden, United States, France, Netherlands
University Hospital, Gasthuisberg

Unknown

Circumferential Section Pane Less Than 1 mm in Esophagectomy for Esophageal Cancer.

Esophageal Cancer

Belgium
University Hospital, Ghent

Completed

Use of 18F-PSMA-11 PET for Detection of Lesions in Iodine Refractory Thyroid Cancers

Thyroid Cancer

Belgium
University of Liege

Unknown

Oral Care Study of Postoperative Infections

Cancer, Mouth

Belgium
AZ Sint-Jan AV

Recruiting

Prospective Registry of Prosthodontic Rehabilitation in Oncology Patients Undergoing Jaw Reconstruction (O-BRIDGE)

Head and Neck Cancer | Osteonecrosis | Osteoradionecrosis

Belgium
University Hospital, Ghent

Terminated

Phase I Trial From GRID 18F-FDG-PET Biological Imaging-guided Intensitymodulated Radiotherapy (BG-IMRT) With Patients With Recurrent or New Head or Neck Tumor in Previously Radiated Area

Head and Neck Tumors

Belgium
Genentech, Inc.

Completed

A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN)

Head and Neck Cancer

Belgium, United States
European Organisation for Research and Treatment...

Completed

BI 2536 in Treating Patients With Recurrent or Metastatic Solid Tumors

Sarcoma | Breast Cancer | Head and Neck Cancer | Ovarian Cancer | Endometrial Cancer | Melanoma (Skin)

Belgium
University of Liege

Completed

Controlled Study of Stage 3 Osteonecrosis Treatment by Bone Marrow

Non Traumatic Osteonecrosis of the Femoral Head (Hip)

Belgium
Jules Bordet Institute

Completed

Phase 1 Study Testing the Combination of Aflibercept and Capecitabine in Metastatic Digestive and Breast Cancers (MOMENTUM1)

Metastatic Colorectal Cancers | Metastatic Gastric Cancers | Metastatic Oesophageal Cancers | Metastatic Pancreatic Cancers | Metastatic Biliary Cancers | Metastatic Breast Cancers

Belgium
Cliniques universitaires Saint-Luc- Université...

Completed

Profile of Plasma Growth Factors Before and After Head and Neck Oncological or Non-oncological Surgery (HNSCC)

Surgery | Head and Neck Squamous Cell Carcinoma | Growth Factor

Belgium
Genzyme, a Sanofi Company

Completed

CAPRELSA® REGISTRY: a Belgian Registry to Evaluate the Use of Vandetanib (Caprelsa®) in Current Clinical Practice (CaprelsaReg)

Metastatic Medullary Thyroid Cancer

Belgium
Erasme University Hospital
University of Liege; Bone Therapeutics S.A

Completed

Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head (PREOB-ON2)

Avascular Necrosis of Femur Head

Belgium
Genmab

Terminated

Zalutumumab in Combination With Radiotherapy in Head and Neck Cancer Patients Ineligible for Platinum Based Chemotherapy

Head and Neck Cancer | Squamous Cell Carcinoma

United Kingdom, Belgium, France
Ipsen

Terminated

Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.

Gastric Cancer | Colorectal Cancer | Bone Cancer | Squamous Cell Carcinoma of the Head and Neck | Advanced Cancer | Recurrent Disease | Pancreatic Ductal Adenocarcinoma | Metastatic Tumours

United States, France, Belgium, Switzerland, Netherlands
Pfizer
EMD Serono; Astellas Pharma Inc; Nektar Therapeutics

Terminated

Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors

Squamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)

Spain, United States, Poland, Belgium
ElmediX

Recruiting

Safety Study of Whole Body Hyperthermia for Advanced Cancer (MATTERS)

Advanced Cancer | Pancreatic Cancer Metastatic

Belgium
iTeos Belgium SA
GlaxoSmithKline; iTeos Therapeutics

Recruiting

Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors (TIG-006)

Melanoma | Head and Neck Cancer | Lung Cancer | Advanced Cancer

Spain, Italy, France, United States, United Kingdom, Belgium

Clinical Trials on Head Cancer in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations